#DeathCross $CRBP at 1.50 R38 HiLo 0% T1Y 8 hold 2.7 fwdPE -1.2 DIV N/A #Corbus Pha #stocks #trading #finance #market

2020-09-24
41 Views

Death Cross detected for CRBP (Corbus Pharmaceutica) at the close price of 1.50. Trading at a 0 % level between the 52week High (9.78) and 52week Low (1.47).
The average analyst 1-year target price is 8.0 with an average hold and a score of 2.7.

Death Cross
38 %
CRBP
1.50
Corbus Pharmaceutica
HiLo
0.4 pc
Support
1.50
Resistance
2.44
50DMA
6.16
200DMA
6.17
52week high
9.78
52week low
1.47
10DMA
1.88
20DMA
4.80
100 Mean
6.76
Volume
6913193
AvgDayVol
3729348
MarketCap
122976704
EBITDA
-119240280
Revenue
7211708
PE
0.00
P2S
0.00
P2B
0.00
Dividend
0.00
Div Ex-Date

Further research links:

Marketwatch Yahoo Finance Google Finance StockTwits

You may be interested

HILO Index 112 Current 91.3 MA20 -12.58 Lower 142.38 Upper Bound #stocks #trading #markets #finance
Global Indicators,
9 views
Global Indicators,
9 views

HILO Index 112 Current 91.3 MA20 -12.58 Lower 142.38 Upper Bound #stocks #trading #markets #finance

Andreas Aigner - 2020-10-20

HILO Index 112 Current 91.3 MA20 -12.58 Lower 142.38 Upper Bound #stocks #trading #markets #finance x

Demark B/S Index -2.15 Avg 26.23 Std 1 Curr #stocks #trading #markets #finance
Global Indicators,
6 views
Global Indicators,
6 views

Demark B/S Index -2.15 Avg 26.23 Std 1 Curr #stocks #trading #markets #finance

Andreas Aigner - 2020-10-20

Demark B/S Index -2.15 Avg 26.23 Std 1 Curr #stocks #trading #markets #finance

50/200 DMA Index 1.92 Avg 3.98 Std 1 Curr #stocks #trading #markets #finance
Global Indicators,
10 views
Global Indicators,
10 views

50/200 DMA Index 1.92 Avg 3.98 Std 1 Curr #stocks #trading #markets #finance

Andreas Aigner - 2020-10-20

50/200 DMA Index 1.92 Avg 3.98 Std 1 Curr #stocks #trading #markets #finance x

Leave a Comment

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

We use Cookies to improve our Site. Your are agreeing to this by continuing to use our Site.